IRWD - Ironwood Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue298,276273,957149,55576,436
Cost of Revenue167,634141,734126,396124,473
Gross Profit130,642132,22323,159-48,037
Operating Expenses
Research Development----
Selling General and Administrative233,123171,681125,247117,133
Non Recurring----
Others----
Total Operating Expenses406,971314,396251,643241,606
Operating Income or Loss-108,695-40,439-102,088-165,170
Income from Continuing Operations
Total Other Income/Expenses Net-8,242-41,269-40,581-24,448
Earnings Before Interest and Taxes-108,695-40,439-102,088-165,170
Interest Expense-36,370-39,153-31,096-21,166
Income Before Tax-116,937-81,708-142,669-189,618
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-116,937-81,708-142,669-189,618
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-116,937-81,708-142,669-189,618
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-116,937-81,708-142,669-189,618